A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1

Journal of Clinical Investigation

Volumn 122, Issue 1, 2012, Pages 327-336

  Pillay, Janesh ^a   Kamp, Vera M ^a   Van Hoffen, Els ^a   Visser, Tjaakje ^a   Tak, Tamar ^a   Lammers, Jan Willem ^a   Ulfman, Laurien H ^a   Leenen, Luke P ^a   Pickkers, Peter ^b   Koenderman, Leo ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD16 ANTIGEN; ENDOTOXIN; GLYCOPROTEIN P 15095; HYDROGEN PEROXIDE; INTEGRIN; INTEGRIN MAC 1; L SELECTIN; SUPPRESSOR FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOLOGICAL SYNAPSE; IN VIVO STUDY; INFLAMMATION; INJURY; NEUTROPHIL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; COCULTURE TECHNIQUES; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGICAL SYNAPSES; INFLAMMATION; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES;

EID: 84855444617     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57990     Document Type: Article

References (45)

1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162-174.
2. Haile LA, et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology. 2008;135(3):871-881.
3. Mencacci A, et al. CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol. 2002;169(6):3180-3190. (Pubitemid 35013164)
4. Morecki S, Gelfand Y, Yacovlev E, Eizik O, Shabat Y, Slavin S. CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy. Biol Blood Marrow Transplant. 2008;14(9):973-984.
5. Movahedi K, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 2008;111(8):4233-4244.
6. Bhardwaj N. Harnessing the immune system to treat cancer. J Clin Invest. 2007;117(5):1130-1136. (Pubitemid 46718397)
7. Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer J. 2010;16(4):348-353.
8. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008;181(8):5791-5802.
9. Almand B, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2001;166(1):678-689. (Pubitemid 32038493)
10. Rodriguez PC, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009;69(4):1553-1560.
11. Zea AH, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005;65(8):3044-3048. (Pubitemid 40524582)
12. Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood. 2007;109(4):1568-1573. (Pubitemid 46239590)
13. Corzo CA, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol. 2009;182(9):5693- 5701.
14. Kusmartsev S, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2008;14(24):8270-8278.
15. Delano MJ, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med. 2007;204(6):1463-1474. (Pubitemid 46919883)
16. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15(5):496-497.
17. Limaye AP, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300(4):413-422. (Pubitemid 352040253)
18. Luyt CE, et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med. 2007;175(9):935-942.
19. Pickkers P, Dorresteijn MJ, Bouw MP, van der Hoeven JG, Smits P. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation. 2006;114(5):414-421. (Pubitemid 44264823)
20. Pillay J, et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol. 2010;88(1):211-220.
21. Fortunati E, Kazemier KM, Grutters JC, Koenderman L, Van den Bosch JM. Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol. 2009;155(3):559-566.
22. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol. 2006;176(4):2085-2094. (Pubitemid 43201655)
23. Kusmartsev SA, Li Y, Chen SH. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol. 2000;165(2):779-785. (Pubitemid 30484744)
24. Roos D, Winterbourn CC. Immunology. Lethal weapons. Science. 2002;296(5568):669-671.
25. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci U S A. 2006;103(34):12831-12836. (Pubitemid 44298647)
26. Klemke M, Wabnitz GH, Funke F, Funk B, Kirchgessner H, Samstag Y. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity. 2008;29(3):404-413.
27. van Spriel AB, et al. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood. 2001;97(8):2478-2486.
28. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346(6283):425-434.
29. Gallin JI. Human neutrophil heterogeneity exists, but is it meaningful? Blood. 1984;63(5):977-983. (Pubitemid 14100894)
30. Otten MA, et al. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J Immunol. 2005;174(9):5472-5480. (Pubitemid 40593187)
31. Taneja R, Sharma AP, Hallett MB, Findlay GP, Morris MR. Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling. Shock. 2008;30(6):618-622.
32. Nakagawa M, Terashima T, D'Yachkova Y, Bondy GP, Hogg JC, van Eeden SF. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation. 1998;98(21):2307-2313. (Pubitemid 28533851)
33. Cheretakis C, Leung R, Sun CX, Dror Y, Glogauer M. Timing of neutrophil tissue repopulation predicts restoration of innate immune protection in a murine bone marrow transplantation model. Blood. 2006;108(8):2821-2826.
34. Pillay J, et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood. 2010;116(4):625-627.
35. Muller I, Munder M, Kropf P, Hansch GM. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 2009;30(11):522-530.
36. Zhang X, Majlessi L, Deriaud E, Leclerc C, LoMan R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity. 2009;31(5):761-771.
37. Jacobsen LC, Theilgaard-Monch K, Christensen EI, Borregaard N. Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood. 2007;109(7):3084-3087. (Pubitemid 46482111)
38. Munder M, et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood. 2005;105(6):2549-2556. (Pubitemid 40387058)
39. Gelderman KA, et al. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest. 2007;117(10):3020-3028. (Pubitemid 47529631)
40. Schoonbroodt S, et al. Crucial role of the aminoterminal tyrosine residue 42 and the carboxylterminal PEST domain of I kappa B alpha in NF-kappaB activation by an oxidative stress. J Immunol. 2000;164(8):4292-4300. (Pubitemid 30215091)
41. Varga G, et al. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood. 2007;109(2):661-669. (Pubitemid 46105967)
42. Rahman FZ, Marks DJ, Hayee BH, Smith AM, Bloom SL, Segal AW. Phagocyte dysfunction and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(10):1443-1452.
43. Abadie V, et al. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood. 2005;106(5):1843-1850. (Pubitemid 41208603)
44. Maletto BA, et al. Presence of neutrophil-bearing antigen in lymphoid organs of immune mice. Blood. 2006;108(9):3094-3102. (Pubitemid 44794225)
45. Verploegen S, van Leeuwen CM, van Deutekom HW, Lammers JW, Koenderman L, Coffer PJ. Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase. Eur J Biochem. 2002;269(18):4625-4634.